Multimodality Imaging in Cardio-Oncology -- Anthracycline/Trastuzumab Cardiac Toxicity -- Immune Checkpoint Inhibitor (ICI)-Associated Myocarditis -- Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy -- Introduction to Tyrosine Kinase Inhibitors: Pazopanib Cardiotoxicity -- Tyrosine Kinase Inhibitors: Arrhythmias and Coagulopathy -- Vascular Toxicity of Tyrosine Kinase Inhibitors: Peripheral Vascular and Coronary Artery Disease -- Vascular Toxicity of Tyrosine Kinase Inhibitors: Coronary Artery Disease -- Vascular Toxicity of Tyrosine Kinase Inhibitors: Pulmonary Hypertension -- Cardiovascular Toxicities of Proteasome Inhibitors -- Cardiac Complications of 5-Flourouracil (5FU) and Capecitabine Therapy -- Cisplatin and Carboplatin -- Cardiac Risk Assessment Prior to Hematopoietic Stem Cell Transplantation: Cases and Management Strategies -- The Role of Myocardial Perfusion Imaging in Cardiac Clearance of Cancer Patients -- Perioperative Management of the Cancer Patient -- Masses Involving the Heart and Vasculature -- Carcinoid Heart Disease -- Cardiac Amyloidosis -- Stress-induced Cardiomyopathy -- Arterial Thrombosis: Marantic Endocarditis -- Pericardial Effusion, Tamponade, and Constrictive Pericarditis -- Introduction to the Cardiac Implications of Radiotherapy -- Cardio-Oncologists' Perspective on the Cardiac Implications of Radiotherapy: Complex Cases of Radiation-related Valvular and Vascular Disease -- Radiation-related Coronary and Conduction System Disease -- Radiation Injury to the Heart, Great Vessels, and Their Branches -- Cardiac Constriction and Restriction After Chest Radiotherapy for Hodgkin's Lymphoma and Breast Cancer -- Onset of Heart Failure After Anthracycline Therapy in the Adult: Treatment and Expectations for Recovery -- Heart Failure in Long-term Survivors of Childhood or Adolescent Cancers -- Health Care Disparities in Cardio-Oncology -- Cardio-Oncology Practice in the Community -- Cardio-Oncology in the COVID-19 Era -- Acute Cardiac Care of Cancer Patients. .